Bio

Clinical Focus


  • Pediatric Neurology
  • Pediatric Stroke

Academic Appointments


Administrative Appointments


  • Director, Stanford Pediatric Stroke Program, Stanford University (2011 - Present)

Honors & Awards


  • National Institute of Neurological Diseases and Stroke (NINDS) Scholarship, NINDS Clinical Trial Methods Course in Neurology, Vail, Colorado (2011)
  • Clinical Research Fellowship Salary Award, Thrombosis Interest Group of Canada (2009)
  • William Logan Resident Teaching Award, Hospital for Sick Children (2009)
  • Prichard Day Award for Excellence in Research, First Prize, Hospital for Sick Children (2008)
  • Florence E. Heighway Summer Research Award, University of British Columbia (2002)
  • Ethlyn Trapp Memorial Scholarship of Medicine, University of British Columbia (2001)
  • Edythe Hembroff-Schleicher Scholarship, University of Victoria (1998)

Professional Education


  • Medical Education:University of British Columbia (2004) BCCanada
  • Fellowship:University of Toronto (2011) Canada
  • M.S., Stanford University, Masters in Clinical Trial Design and Epidemiology (2013)
  • Fellowship, University of Toronto, Pediatric Stroke (2011)
  • Residency:University of Toronto (2009) Canada

Research & Scholarship

Current Research and Scholarly Interests


My clinical research interests focus on the field of pediatric stroke, and include causes of arteriopathies, novel neuroimaging techniques for the diagnosis of arteriopathies, and maximizing functional outcome after stroke in children. As a member of the International Pediatric Stroke Study, we contribute to an international database of children following stroke, thereby facilitating multi-centered research in this area.

Publications

Journal Articles


  • Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial. Stroke; a journal of cerebral circulation Bernard, T. J., Rivkin, M. J., Scholz, K., DeVeber, G., Kirton, A., Gill, J. C., Chan, A. K., Hovinga, C. A., Ichord, R. N., Grotta, J. C., Jordan, L. C., Benedict, S., Friedman, N. R., Dowling, M. M., Elbers, J., Torres, M., Sultan, S., Cummings, D. D., Grabowski, E. F., McMillan, H. J., Beslow, L. A., Amlie-Lefond, C. 2014; 45 (7): 2018-2023

    Abstract

    In adult stroke, the advent of thrombolytic therapy led to the development of primary stroke centers capable to diagnose and treat patients with acute stroke rapidly. We describe the development of primary pediatric stroke centers through preparation of participating centers in the Thrombolysis in Pediatric Stroke (TIPS) trial.We collected data from the 17 enrolling TIPS centers regarding the process of becoming an acute pediatric stroke center with capability to diagnose, evaluate, and treat pediatric stroke rapidly, including use of thrombolytic therapy.Before 2004, <25% of TIPS sites had continuous 24-hour availability of acute stroke teams, MRI capability, or stroke order sets, despite significant pediatric stroke expertise. After TIPS preparation, >80% of sites now have these systems in place, and all sites reported increased readiness to treat a child with acute stroke. Use of a 1- to 10-Likert scale on which 10 represented complete readiness, median center readiness increased from 6.2 before site preparation to 8.7 at the time of site activation (P≤0.001).Before preparing for TIPS, centers interested in pediatric stroke had not developed systematic strategies to diagnose and treat acute pediatric stroke. TIPS trial preparation has resulted in establishment of pediatric acute stroke centers with clinical and system preparedness for evaluation and care of children with acute stroke, including use of a standardized protocol for evaluation and treatment of acute arterial stroke in children that includes use of intravenous tissue-type plasminogen activator.http://www.clinicaltrials.gov. Unique identifier: NCT01591096.

    View details for DOI 10.1161/STROKEAHA.114.004919

    View details for PubMedID 24916908

  • Emergence of the Primary Pediatric Stroke Center Impact of the Thrombolysis in Pediatric Stroke Trial STROKE Bernard, T. J., Rivkin, M. J., Scholz, K., DeVeber, G., Kirton, A., Gill, J. C., Chan, A. K., Hovinga, C. A., Ichord, R. N., Grotta, J. C., Jordan, L. C., Benedict, S., Friedman, N. R., Dowling, M. M., Elbers, J., Torres, M., Sultan, S., Cummings, D. D., Grabowski, E. F., McMillan, H. J., Beslow, L. A., Amlie-Lefond, C. 2014; 45 (7): 2018-2023
  • Long-Term Outcomes of Pediatric Ischemic Stroke in Adulthood JOURNAL OF CHILD NEUROLOGY Elbers, J., DeVeber, G., Pontigon, A., Moharir, M. 2014; 29 (6): 782-788
  • Long-term Outcomes of Pediatric Ischemic Stroke in Adulthood Journal of Child Neurology Elbers J, deVeber G, Pontigon AM & Moharir M.
  • Placental Pathology and Neonatal Stroke. Pediatrics Elbers J, Viero S, MacGregor D, deVeber G, & Moore AM 2011; 127 (3): 722-9
  • Brain biopsy characteristics in children with small vessel central nervous system vasculitis Annals of Neurology Elbers J, Halliday W, Hawkins C, Hutchinson C, & Benseler SM 2010; 68 (5): 602-610
  • Navigating an International Research Elective in a Resource-Poor Setting Canadian Journal of Neurological Sciences Elbers J 2010; 37 (6): 909-911
  • . Treatment of small vessel primary CNS vasculitis in children: An open-label cohort study. Lancet Neurology Hutchinson C, Elbers J, Halliday W, Branson H, Laughlin S, Armstrong D, Hawkins C 2010; 9 (11): 1078-1084
  • Central nervous system vasculitis in children. Current Opinion in Rheumatology Elbers J, Benseler SM 2008; 20 (1): 47-54
  • The ages and stages questionnaires: Feasibility of use as a screening tool for children in Canada Canadian Journal of Rural Medicine Elbers J, Macnab A, McLeod E, & Gagnon F 2008; 13 (1): 9-14
  • A 12-year prospective study of childhood herpes simplex encephalitis: Is there a broader spectrum of disease? Pediatrics Elbers J, Bitnun A, Richardson S, Ford-Jones L, & Tellier R 2007; 119 (2): e399-e407

Stanford Medicine Resources: